Epoch 32 - Hot Capital is Back in Biotech?
The Trifecta of M&A, Positive Data Readouts, and Macro Tailwinds
Welcome to the 41 NEW Biotech Innovators who have joined us this month! If you haven’t subscribed, join the 710 researchers, investors, operators, academics, clinicians and entrepreneurs by subscribing here:
Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on delivering a general market updat…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.